Fate Therapeutics
FATE
FATE
149 hedge funds and large institutions have $1.15B invested in Fate Therapeutics in 2019 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 56 increasing their positions, 42 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
1.1% more ownership
Funds ownership: 96.88% → 97.98% (+1.1%)
11% less capital invested
Capital invested by funds: $1.28B → $1.15B (-$137M)
12% less call options, than puts
Call options by funds: $3.97M | Put options by funds: $4.51M
Holders
149
Holding in Top 10
6
Calls
$3.97M
Puts
$4.51M
Top Buyers
| 1 | +$35.5M | |
| 2 | +$20.7M | |
| 3 | +$13.3M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$12.4M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$12M |
Top Sellers
| 1 | -$10.4M | |
| 2 | -$9.66M | |
| 3 | -$8.23M | |
| 4 |
PVMCV
Polaris Venture Management Co V
Boston,
Massachusetts
|
-$5.18M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$4.82M |